US Stock MarketDetailed Quotes

CYCCP Cyclacel Pharmaceuticals Inc

Watchlist

6.610
-0.360-5.16%

Close Nov 15 16:00 ET

79.30MMarket Cap0.00P/E (TTM)

Cyclacel Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-136.32%-3.08M

92.96%-483K

22.64%-16.11M

24.36%-3.91M

42.08%-4.04M

31.85%-1.31M

-1.27%-6.86M

-12.34%-20.83M

-13.63%-5.17M

-12.21%-6.97M

Net income from continuing operations

40.22%-3.26M

49.24%-2.95M

-6.40%-22.56M

28.95%-5.27M

-18.37%-6.03M

-19.08%-5.45M

-41.29%-5.8M

-14.85%-21.2M

-52.53%-7.42M

-2.17%-5.1M

Depreciation and amortization

-75.00%2K

-3.13%31K

0.00%8K

0.00%7K

0.00%8K

-11.11%8K

-25.58%32K

14.29%8K

-30.00%7K

Other non cash items

-14.29%-16K

38.46%-16K

----

---14K

-73.33%-26K

----

Change In working capital

-100.05%-2K

257.92%2.27M

523.22%4.94M

-44.42%1.03M

168.69%1.56M

65.72%3.79M

52.65%-1.44M

9.04%-1.17M

46,275.00%1.86M

-46.13%-2.27M

-Change in prepaid assets

-74.00%1.18M

263.70%2.02M

224.52%4.71M

239.26%1.35M

103.97%75K

41.34%4.52M

70.09%-1.23M

15.54%-3.78M

46.96%-968K

13.26%-1.89M

-Change in payables and accrued expense

-60.71%-1.18M

223.30%254K

-88.51%296K

-110.78%-303K

477.89%1.54M

19.72%-733K

-118.99%-206K

-14.81%2.58M

53.66%2.81M

-171.53%-407K

-Change in other current liabilities

----

-272.50%-69K

-227.27%-14K

----

-76.74%40K

1,200.00%11K

----

Cash from discontinued investing activities

Operating cash flow

-136.32%-3.08M

92.96%-483K

22.64%-16.11M

24.36%-3.91M

42.08%-4.04M

31.85%-1.31M

-1.27%-6.86M

-12.34%-20.83M

-13.63%-5.17M

-12.21%-6.97M

Investing cash flow

Cash flow from continuing investing activities

14.29%-6K

-50.00%-6K

74.07%-7K

Net PPE purchase and sale

--0

14.29%-6K

--0

-50.00%-6K

74.07%-7K

--0

Cash from discontinued investing activities

Investing cash flow

--0

14.29%-6K

--0

-50.00%-6K

74.07%-7K

--0

Financing cash flow

Cash flow from continuing financing activities

12,431.37%6.29M

-58.00%-79K

-71.71%848K

2,278.57%999K

-103.26%-50K

-103.46%-51K

0.00%-50K

-86.21%3M

-95.26%42K

-47.25%1.53M

Net common stock issuance

----

-67.21%1.05M

1,040.22%1.05M

--0

----

-81.58%3.2M

102.53%92K

-46.45%1.58M

Cash dividends paid

--0

0.00%-201K

0.00%-50K

0.00%-51K

0.00%-50K

0.00%-201K

0.00%-50K

Net other financing activities

----

---79K

----

Cash from discontinued financing activities

Financing cash flow

12,431.37%6.29M

-58.00%-79K

-71.71%848K

2,278.57%999K

-103.26%-50K

-103.46%-51K

0.00%-50K

-86.21%3M

-95.26%42K

-47.25%1.53M

Net cash flow

Beginning cash position

-75.53%2.8M

-81.59%3.38M

-49.82%18.35M

-74.93%5.94M

-65.04%10.16M

-61.42%11.44M

-49.82%18.35M

9.44%36.56M

-41.06%23.71M

-33.37%29.08M

Current changes in cash

336.36%3.21M

91.88%-562K

14.39%-15.27M

43.22%-2.91M

24.83%-4.09M

-205.41%-1.36M

-1.29%-6.92M

-662.65%-17.84M

-39.93%-5.13M

-63.98%-5.44M

Effect of exchange rate changes

-103.53%-3K

-357.14%-18K

180.16%303K

247.44%345K

-306.15%-134K

172.03%85K

107.69%7K

-2,123.53%-378K

-5,950.00%-234K

161.90%65K

End cash Position

-40.97%6M

-75.53%2.8M

-81.59%3.38M

-74.93%5.94M

-65.04%10.16M

-61.42%11.44M

-49.82%18.35M

-41.06%23.71M

Free cash flow

-136.32%-3.08M

92.97%-483K

22.64%-16.12M

24.36%-3.91M

42.08%-4.04M

31.96%-1.31M

-1.30%-6.87M

-12.21%-20.83M

-13.58%-5.17M

-12.04%-6.97M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-136.32%-3.08M	92.96%-483K	22.64%-16.11M	24.36%-3.91M	42.08%-4.04M	31.85%-1.31M	-1.27%-6.86M	-12.34%-20.83M	-13.63%-5.17M	-12.21%-6.97M
Net income from continuing operations	40.22%-3.26M	49.24%-2.95M	-6.40%-22.56M	28.95%-5.27M	-18.37%-6.03M	-19.08%-5.45M	-41.29%-5.8M	-14.85%-21.2M	-52.53%-7.42M	-2.17%-5.1M
Depreciation and amortization	-75.00%2K	-75.00%2K	-3.13%31K	0.00%8K	0.00%7K	0.00%8K	-11.11%8K	-25.58%32K	14.29%8K	-30.00%7K
Other non cash items	-14.29%-16K	38.46%-16K	----	----	----	---14K	-73.33%-26K	----	----	----
Change In working capital	-100.05%-2K	257.92%2.27M	523.22%4.94M	-44.42%1.03M	168.69%1.56M	65.72%3.79M	52.65%-1.44M	9.04%-1.17M	46,275.00%1.86M	-46.13%-2.27M
-Change in prepaid assets	-74.00%1.18M	263.70%2.02M	224.52%4.71M	239.26%1.35M	103.97%75K	41.34%4.52M	70.09%-1.23M	15.54%-3.78M	46.96%-968K	13.26%-1.89M
-Change in payables and accrued expense	-60.71%-1.18M	223.30%254K	-88.51%296K	-110.78%-303K	477.89%1.54M	19.72%-733K	-118.99%-206K	-14.81%2.58M	53.66%2.81M	-171.53%-407K
-Change in other current liabilities	----	----	-272.50%-69K	-227.27%-14K	----	----	----	-76.74%40K	1,200.00%11K	----
Cash from discontinued investing activities
Operating cash flow	-136.32%-3.08M	92.96%-483K	22.64%-16.11M	24.36%-3.91M	42.08%-4.04M	31.85%-1.31M	-1.27%-6.86M	-12.34%-20.83M	-13.63%-5.17M	-12.21%-6.97M
Investing cash flow
Cash flow from continuing investing activities	0	0	14.29%-6K	0	0	0	-50.00%-6K	74.07%-7K	0	0
Net PPE purchase and sale	--0	--0	14.29%-6K	--0	--0	--0	-50.00%-6K	74.07%-7K	--0	--0
Cash from discontinued investing activities
Investing cash flow	--0	--0	14.29%-6K	--0	--0	--0	-50.00%-6K	74.07%-7K	--0	--0
Financing cash flow
Cash flow from continuing financing activities	12,431.37%6.29M	-58.00%-79K	-71.71%848K	2,278.57%999K	-103.26%-50K	-103.46%-51K	0.00%-50K	-86.21%3M	-95.26%42K	-47.25%1.53M
Net common stock issuance	----	----	-67.21%1.05M	1,040.22%1.05M	--0	----	----	-81.58%3.2M	102.53%92K	-46.45%1.58M
Cash dividends paid	--0	--0	0.00%-201K	0.00%-50K	0.00%-50K	0.00%-51K	0.00%-50K	0.00%-201K	0.00%-50K	0.00%-50K
Net other financing activities	----	---79K	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	12,431.37%6.29M	-58.00%-79K	-71.71%848K	2,278.57%999K	-103.26%-50K	-103.46%-51K	0.00%-50K	-86.21%3M	-95.26%42K	-47.25%1.53M
Net cash flow
Beginning cash position	-75.53%2.8M	-81.59%3.38M	-49.82%18.35M	-74.93%5.94M	-65.04%10.16M	-61.42%11.44M	-49.82%18.35M	9.44%36.56M	-41.06%23.71M	-33.37%29.08M
Current changes in cash	336.36%3.21M	91.88%-562K	14.39%-15.27M	43.22%-2.91M	24.83%-4.09M	-205.41%-1.36M	-1.29%-6.92M	-662.65%-17.84M	-39.93%-5.13M	-63.98%-5.44M
Effect of exchange rate changes	-103.53%-3K	-357.14%-18K	180.16%303K	247.44%345K	-306.15%-134K	172.03%85K	107.69%7K	-2,123.53%-378K	-5,950.00%-234K	161.90%65K
End cash Position	-40.97%6M	-75.53%2.8M	-81.59%3.38M	-81.59%3.38M	-74.93%5.94M	-65.04%10.16M	-61.42%11.44M	-49.82%18.35M	-49.82%18.35M	-41.06%23.71M
Free cash flow	-136.32%-3.08M	92.97%-483K	22.64%-16.12M	24.36%-3.91M	42.08%-4.04M	31.96%-1.31M	-1.30%-6.87M	-12.21%-20.83M	-13.58%-5.17M	-12.04%-6.97M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data